Denali Therapeutics Inc
NASDAQ:DNLI

Watchlist Manager
Denali Therapeutics Inc Logo
Denali Therapeutics Inc
NASDAQ:DNLI
Watchlist
Price: 16.58 USD -1.72%
Market Cap: 2.4B USD

Wall Street
Price Targets

DNLI Price Targets Summary
Denali Therapeutics Inc

Wall Street analysts forecast DNLI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DNLI is 32.48 USD with a low forecast of 24.24 USD and a high forecast of 42 USD.

Lowest
Price Target
24.24 USD
46% Upside
Average
Price Target
32.48 USD
96% Upside
Highest
Price Target
42 USD
153% Upside
Denali Therapeutics Inc Competitors:
Price Targets
ONCO
Oncopeptides AB
7% Upside
KURN
Kuros Biosciences AG
27% Upside
BONEX
Bonesupport Holding AB
117% Upside
PTCT
PTC Therapeutics Inc
7% Upside
688363
Bloomage Biotechnology Corp Ltd
10% Upside
1801
Innovent Biologics Inc
36% Upside
DVYSR
Devyser Diagnostics AB
48% Upside
VCEL
Vericel Corp
49% Upside

Revenue
Forecast

Revenue Estimate
Denali Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Denali Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Denali Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-17%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DNLI's stock price target?
Price Target
32.48 USD

According to Wall Street analysts, the average 1-year price target for DNLI is 32.48 USD with a low forecast of 24.24 USD and a high forecast of 42 USD.

Back to Top